COPN.SW
Price:
$65.4
Market Cap:
$1.11B
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diagnostic drug to enhance pre-cancerous and cancerous detection of colorectal lesions during colonoscopy. The company also provides Eleview, an injectable composition for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancer...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2007-03-12
Stock Exchange
SIX
Ticker
COPN.SW
According to Cosmo Pharmaceuticals N.V.’s latest financial reports and current stock price. The company's current Current Ratio is 4.85. This represents a change of 9.88% compared to the average of 4.41 of the last 4 quarters.
The mean historical Current Ratio of Cosmo Pharmaceuticals N.V. over the last ten years is 10.06. The current 4.85 Current Ratio has changed 4.72% with respect to the historical average. Over the past ten years (40 quarters), COPN.SW's Current Ratio was at its highest in in the September 2018 quarter at 24.38. The Current Ratio was at its lowest in in the September 2014 quarter at 1.17.
Average
10.06
Median
10.07
Minimum
1.17
Maximum
24.38
Discovering the peaks and valleys of Cosmo Pharmaceuticals N.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 372.49%
Maximum Annual Current Ratio = 24.38
Minimum Annual Increase = -94.00%
Minimum Annual Current Ratio = 1.17
Year | Current Ratio | Change |
---|---|---|
2023 | 3.98 | 153.19% |
2022 | 1.57 | -87.91% |
2021 | 12.99 | 11.95% |
2020 | 11.60 | -39.73% |
2019 | 19.25 | -21.04% |
2018 | 24.38 | 140.15% |
2017 | 10.15 | 1.59% |
2016 | 9.99 | 81.46% |
2015 | 5.51 | 372.49% |
2014 | 1.17 | -94.00% |
The current Current Ratio of Cosmo Pharmaceuticals N.V. (COPN.SW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.18
5-year avg
9.88
10-year avg
10.06
Cosmo Pharmaceuticals N.V.’s Current Ratio is greater than Basilea Pharmaceutica AG (4.10), greater than Newron Pharmaceuticals S.p.A. (3.73), greater than Santhera Pharmaceuticals Holding AG (0.63), less than Evolva Holding SA (8.91), less than Addex Therapeutics Ltd (4.97),
Company | Current Ratio | Market cap |
---|---|---|
4.10 | $520.60M | |
3.73 | $152.34M | |
0.63 | $106.05M | |
8.91 | $6.76M | |
4.97 | $15.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cosmo Pharmaceuticals N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cosmo Pharmaceuticals N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Cosmo Pharmaceuticals N.V.'s Current Ratio?
How is the Current Ratio calculated for Cosmo Pharmaceuticals N.V. (COPN.SW)?
What is the highest Current Ratio for Cosmo Pharmaceuticals N.V. (COPN.SW)?
What is the 3-year average Current Ratio for Cosmo Pharmaceuticals N.V. (COPN.SW)?
What is the 5-year average Current Ratio for Cosmo Pharmaceuticals N.V. (COPN.SW)?
How does the current Current Ratio for Cosmo Pharmaceuticals N.V. (COPN.SW) compare to its historical average?